Tesofensine (formerly known as NS2330) was originally developed by a Danish company, NeuroSearch, for neurodegenerative diseases like Alzheimer's and Parkinson's. During those trials, a significant side effect was observed: substantial weight loss. This led to its re-development as a potential obesity treatment.
How Does It Work? (The Mechanism)
Tesofensine's potency comes from its unique triple mechanism of action. It is a serotonin–noradrenaline–dopamine reuptake inhibitor (SNDRI). This means it increases the levels of three key neurotransmitters in the brain:
Dopamine: Influences reward and motivation, but crucially, also helps regulate metabolism and reduce hunger.
Norepinephrine (Noradrenaline): Increases metabolic rate and energy expenditure (you burn more calories at rest).
Serotonin: Promotes feelings of fullness and satiety after eating.
By hitting all three systems simultaneously, it powerfully suppresses appetite and boosts metabolism. This is different from most other drugs:
GLP-1 agonists (like semaglutide - Wegovy/Ozempic) primarily work on hormones in the gut and brain to promote satiety.
Older medications often targeted only one or two neurotransmitters.
3. The Evidence: Clinical Trial Results
The most cited and significant evidence comes from a 2013 randomized, double-blind, placebo-controlled phase II trial (the gold standard for clinical evidence):
Participants: 203 obese patients.
Dosage: 0.25 mg, 0.5 mg, or 1.0 mg of tesofensine per day vs. placebo.
Duration: 24 weeks.
Results:
Placebo group: Lost an average of 2.2 kg (~4.8 lbs).
0.25 mg group: Lost an average of 6.7 kg (~14.8 lbs).
0.5 mg group: Lost an average of 11.3 kg (~24.9 lbs). This was the most effective and best-tolerated dose.
1.0 mg group: Lost an average of 12.8 kg (~28.2 lbs), but with a much higher rate of side effects.
This ~10% body weight loss in 6 months is highly impressive and places it in the same league as the most effective current medications.
4. Side Effects and Safety Concerns
This is the critical part. The side effects are similar to other stimulant-like weight loss drugs and are dose-dependent:
Common side effects: Dry mouth, nausea, constipation, insomnia, and increased heart rate.
The major concern: Tesofensine increased heart rate and blood pressure in a significant number of participants. This is a well-known risk with drugs that affect norepinephrine and is a primary reason why it has not yet gained widespread approval. Regulators like the FDA are extremely cautious about cardiovascular risks in weight loss drugs.
The 0.5 mg dose showed a much more acceptable side effect profile than the 1.0 mg dose, suggesting a lower dose could be the key to balancing efficacy and safety.
5. Current Status and Availability
Not Approved: Tesofensine is not FDA-approved and is not legally available as a prescription medication in the US, UK, EU, or Canada.
Patent and Development: The patent was acquired by the Danish company Saniona, which is conducting further trials. They are investigating a low-dose combination therapy (tesofensine with other compounds) to maximize weight loss while minimizing side effects.
"Research Chemical" Market: Despite not being approved, tesofensine is often sold online as a "research chemical" or "not for human consumption." Purchasing it from these sources is extremely risky. The purity, dosage, and safety of these products are completely unverified, posing a significant health danger.
Conclusion: Does It Really Work?
Efficacy: ✔️ Yes, it works. The scientific evidence from clinical trials is strong and demonstrates that it is a potent agent for weight loss.
Safety and Approval: ❌ Not yet. The significant side effects, particularly on heart rate and blood pressure, have prevented its approval so far. It remains an investigational drug.
https://www.hormonerawsource.com/steroid-finished/steroid-finished-tablets/stromusc-tesofensine-500mcg-tablets-for.html
